Oncology & Cancer

Targeted therapy extends survival in cancers of unknown primary

If metastases occur in the body, but the original tumor remains undetectable, this is referred to as "cancer of unknown primary" (CUP). But if information on the tissue of origin is missing, neither organ-specific chemotherapy ...

Diseases, Conditions, Syndromes

AI model can predict continuous renal replacement therapy survival

A UCLA-led team has developed a machine-learning model that can predict with a high degree of accuracy the short-term survival of dialysis patients on continuous renal replacement therapy (CRRT). The study is published in ...

Oncology & Cancer

Measuring 'quality of life' is an important trend in cancer care

As novel cancer treatments continually emerge, it is essential to collect data on patients' quality of life along with how the treatment is working to extend survival. This is particularly true in young people with cancer ...

page 1 from 2